My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Horizon Therapeutics Public Limited Company - Ordinary Shares (NQ:HZNP)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Horizon Therapeutics Public Limited Company - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Expert Ratings for Horizon Therapeutics ↗

August 04, 2022

Analysts have provided the following ratings for Horizon Therapeutics (NASDAQ:HZNP) within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022 ↗

August 04, 2022

Upgrades

Via Benzinga

Nasdaq Surges Over 300 Points; Moderna Earnings Beat Expectations ↗

August 03, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 300 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 03, 2022

Via Benzinga

Horizon Therapeutics' Shares Tumble On Q2 Miss, Trimmed FY22 Outlook ↗

August 03, 2022

Via Benzinga

Analyst Ratings for Horizon Therapeutics ↗

July 05, 2022

Analysts have provided the following ratings for Horizon Therapeutics (NASDAQ:HZNP) within the last quarter:

Via Benzinga

This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday ↗

August 04, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.

Via Benzinga

Analyst Ratings for Horizon Therapeutics ↗

June 14, 2022

Horizon Therapeutics (NASDAQ:HZNP) has observed the following analyst ratings within the last quarter:

Via Benzinga

4 Analysts Have This to Say About Horizon Therapeutics ↗

May 23, 2022

Horizon Therapeutics (NASDAQ:HZNP) has observed the following analyst ratings within the last quarter:

Via Benzinga

Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session ↗

August 03, 2022

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.

Via Benzinga

Horizon Therapeutics: Q1 Earnings Insights ↗

May 04, 2022

Horizon Therapeutics (NASDAQ:HZNP) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Horizon Therapeutics' Inebilizumab Scores European Approval For Spinal Cord Inflammation ↗

May 02, 2022

Via Benzinga

Dow Jumps 350 Points; Crude Oil Drops Over 2% ↗

August 03, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 350 points on Wednesday.

Via Benzinga

AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday ↗

August 03, 2022

Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results.

Via Benzinga

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗

August 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 03, 2022

Via Benzinga

Horizon Therapeutics: Q2 Earnings Insights ↗

August 03, 2022

Horizon Therapeutics (NASDAQ:HZNP) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Biotech Investors: August's Key PDUFA Catalysts You Must Know ↗

July 31, 2022

Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the...

Via Benzinga

Horizon Therapeutics Receives FDA Approval For Uncontrolled Gout Candidate ↗

July 08, 2022

The U.S. Food and Drug Administration (FDA) has approved Horizon Therapeutics’ (NASDAQ: HZNP) supplemental Biologics License Application (sBLA) for expanding the labeling to include KRYSTEXXA...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates ↗

July 01, 2022

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022 ↗

June 14, 2022

Upgrades

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates ↗

May 31, 2022

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,...

Via Benzinga

The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More ↗

May 30, 2022

Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022 ↗

May 24, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022 ↗

May 23, 2022

Via Benzinga

Horizon Therapeutics Earnings Perspective: Return On Capital Employed ↗

May 19, 2022

According to Benzinga Pro, during Q1, Horizon Therapeutics (NASDAQ:HZNP) earned $204.26 million, a 17.95% increase from the preceding quarter. Horizon Therapeutics's sales decreased to $885.25 million,...

Via Benzinga

Horizon Therapeutics Begins Patient Enrolment in Phase 2 trial of Daxdilimab (HZN-7734) for Alopecia Areata ↗

May 17, 2022

Horizon Therapeutics plc (NASDAQ: HZNP) enrolled first patient in a Phase 2, open-label, proof-of-concept trial of its drug candidate Daxdilimab (HZN-7734) to treat people with moderate-to-severe...

Via Benzinga

Stock Market Jumps, Then Dives After Fed Rate Hikes As Treasury Yields Soar: Weekly Review ↗

May 06, 2022

Lithium plays jump on earnings, but Nasdaq at lowest level since 2020.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 02, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

A Peek Into The Markets: US Stock Futures Higher Following Friday's Sell-Off ↗

May 02, 2022

Pre-open movers

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.